Literature DB >> 28013236

Comparing genome versus proteome-based identification of clinical bacterial isolates.

Valentina Galata1, Christina Backes1, Cédric Christian Laczny1, Georg Hemmrich-Stanisak2, Howard Li3, Laura Smoot4, Andreas Emanuel Posch5, Susanne Schmolke5, Markus Bischoff6, Lutz von Müller6, Achim Plum7, Andre Franke2, Andreas Keller1.   

Abstract

Whole-genome sequencing (WGS) is gaining importance in the analysis of bacterial cultures derived from patients with infectious diseases. Existing computational tools for WGS-based identification have, however, been evaluated on previously defined data relying thereby unwarily on the available taxonomic information.Here, we newly sequenced 846 clinical gram-negative bacterial isolates representing multiple distinct genera and compared the performance of five tools (CLARK, Kaiju, Kraken, DIAMOND/MEGAN and TUIT). To establish a faithful 'gold standard', the expert-driven taxonomy was compared with identifications based on matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) analysis. Additionally, the tools were also evaluated using a data set of 200 Staphylococcus aureus isolates.CLARK and Kraken (with k =31) performed best with 626 (100%) and 193 (99.5%) correct species classifications for the gram-negative and S. aureus isolates, respectively. Moreover, CLARK and Kraken demonstrated highest mean F-measure values (85.5/87.9% and 94.4/94.7% for the two data sets, respectively) in comparison with DIAMOND/MEGAN (71 and 85.3%), Kaiju (41.8 and 18.9%) and TUIT (34.5 and 86.5%). Finally, CLARK, Kaiju and Kraken outperformed the other tools by a factor of 30 to 170 fold in terms of runtime.We conclude that the application of nucleotide-based tools using k-mers-e.g. CLARK or Kraken-allows for accurate and fast taxonomic characterization of bacterial isolates from WGS data. Hence, our results suggest WGS-based genotyping to be a promising alternative to the MS-based biotyping in clinical settings. Moreover, we suggest that complementary information should be used for the evaluation of taxonomic classification tools, as public databases may suffer from suboptimal annotations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28013236     DOI: 10.1093/bib/bbw122

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  4 in total

1.  Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model.

Authors:  Fabian Bernhard; Rajesh Odedra; Sylvie Sordello; Rossella Cardin; Samantha Franzoni; Cédric Charrier; Adam Belley; Peter Warn; Matthias Machacek; Philipp Knechtle
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

2.  Integrating Culture-based Antibiotic Resistance Profiles with Whole-genome Sequencing Data for 11,087 Clinical Isolates.

Authors:  Valentina Galata; Cédric C Laczny; Christina Backes; Georg Hemmrich-Stanisak; Susanne Schmolke; Andre Franke; Eckart Meese; Mathias Herrmann; Lutz von Müller; Achim Plum; Rolf Müller; Cord Stähler; Andreas E Posch; Andreas Keller
Journal:  Genomics Proteomics Bioinformatics       Date:  2019-05-14       Impact factor: 7.691

3.  Species Identification and Antibiotic Resistance Prediction by Analysis of Whole-Genome Sequence Data by Use of ARESdb: an Analysis of Isolates from the Unyvero Lower Respiratory Tract Infection Trial.

Authors:  Ines Ferreira; Stephan Beisken; Lukas Lueftinger; Thomas Weinmaier; Matthias Klein; Johannes Bacher; Robin Patel; Arndt von Haeseler; Andreas E Posch
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

4.  Identification and characterization of OmpT-like proteases in uropathogenic Escherichia coli clinical isolates.

Authors:  Isabelle Desloges; James A Taylor; Jean-Mathieu Leclerc; John R Brannon; Andrea Portt; John D Spencer; Ken Dewar; Gregory T Marczynski; Amee Manges; Samantha Gruenheid; Hervé Le Moual; Jenny-Lee Thomassin
Journal:  Microbiologyopen       Date:  2019-09-08       Impact factor: 3.904

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.